OpenLegislation

Council Directive of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices (90/385/EEC)

EU Directive 1990/385 · Adopted 20 June 1990 · Extends to United Kingdom

Original text. legislation.gov.uk does not revise this item, so later amendments are not shown here. Changes made to it are listed under each provision when known.

Council Directive

of 20 June 1990

on the approximation of the laws of the Member States relating to active implantable medical devices

(90/385/EEC)

THE COUNCIL OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100a thereof,

Having regard to the proposal from the Commissionf1,

In cooperation with the European Parliamentf2,

Having regard to the opinion of the Economic and Social Committeef3,

Whereas in each Member State active implantable medical devices must give patients, users and other persons a high level of protection and achieve the intended level of performance when implanted in human beings;

Whereas several Member States have sought to ensure that level of safety by mandatory specifications relating both to the technical safety features and the inspection procedures for such devices; whereas those specifications differ from one Member State to another;

Whereas national provisions ensuring that safety level should be harmonized in order to guarantee the free movement of active implantable medical devices without lowering existing and justified levels of safety in the Member States;

Whereas harmonized measures must be distinguished from measures taken by Member States to manage the financing of public health and sickness insurance schemes directly or indirectly concerning such devices; whereas, therefore, such provisions do not affect the right of Member States to implement the abovementioned measures in compliance with Community law;

Whereas maintaining or improving the level of protection achieved in Member States constitutes one of this Directive's essential objectives as defined by the essential requirements;

Whereas rules governing active implantable medical devices can be confined to those provisions needed to satisfy the essential requirements; whereas, because they are essential, these requirements must replace corresponding national provisions;

Whereas, in order to facilitate proof of conformity with these essential requirements and to permit monitoring of that conformity, it is desirable to have Europe-wide harmonized standards in respect of the prevention of risks in connection with the design, manufacture and packaging of active implantable medical devices; whereas such standards harmonized at European level are drawn up by private-law bodies and must retain their status as non-mandatory texts; whereas, to that end, the European Committee for Standardization (CEN) and the European Committee for Electrotechnical Standardization (Cenelec) are recognized as being the competent bodies to adopt harmonized standards in accordance with the general guidelines for cooperation between the Commission and these two bodies, signed on 13 November 1984; whereas, for the purposes of this Directive, a harmonized standard is a technical specification (European standard or harmonization document) adopted by either or both of these bodies, as instructed by the Commission pursuant to the provisions of Council Directive 83/189/EEC of 28 March 1983 laying down a procedure for the provision of information in the field of technical standards and regulationsf4, as last amended by Directive 88/182/EECf5, and under the abovementioned general guidelines;

Whereas evaluation procedures have to be established and accepted by common accord between the Member States in accordance with Community criteria;

Whereas the specific nature of the medical sector makes it advisable to make provision for the notified body and the manufacturer or his agent established in the Community to fix, by common accord, the time limits for completion of the evaluation and verification operations for the conformity of devices,

HAS ADOPTED THIS DIRECTIVE:

Annotations to the whole text

Footnotes

f1

OJ No C 14, 18.1.1989, p. 4.

f2

OJ No C 120, 16.5.1989, p. 75, and

OJ No C 149, 18.6.1990.

f3

OJ No C 159, 26.6.1989, p. 47.

f4

OJ No L 109, 26.4.1983, p. 8.

f5

OJ No L 81, 26.3.1988, p. 75.

Contents

  1. 1Article 1
  2. 2Article 2
  3. 3Article 3
  4. 4Article 4
  5. 5Article 5
  6. 6Article 6
  7. 7Article 7
  8. 8Article 8
  9. 9Article 9
  10. 9aArticle 9a
  11. 10Article 10
  12. 10aArticle 10a
  13. 10bArticle 10b
  14. 10cArticle 10c
  15. 11Article 11
  16. 12Article 12
  17. 13Article 13
  18. 14Article 14
  19. 15Article 15
  20. 15aArticle 15a
  21. 16Article 16
  22. 17Article 17
  23. Annex 1: ESSENTIAL REQUIREMENTS
  24. GENERAL REQUIREMENTS
  25. 1Division 1
  26. 2Division 2
  27. 3Division 3
  28. 4Division 4
  29. 5Division 5
  30. 5aDivision 5a
  31. REQUIREMENTS REGARDING DESIGN AND CONSTRUCTION
  32. 6Division 6
  33. 7Division 7
  34. 8Division 8
  35. 9Division 9
  36. 10Division 10
  37. 11Division 11
  38. 12Division 12
  39. 13Division 13
  40. 14Division 14
  41. 14.1Division 14.1
  42. 14.2Division 14.2
  43. 15Division 15
  44. 16Division 16
  45. Annex 2: EC DECLARATION OF CONFORMITY
  46. 1Division 1
  47. 2Division 2
  48. Quality system
  49. 3.1Division 3.1
  50. 3.2Division 3.2
  51. 3.3Division 3.3
  52. 3.4Division 3.4
  53. Examination of the design of the product
  54. 4.1Division 4.1
  55. 4.2Division 4.2
  56. 4.3Division 4.3
  57. 4.4Division 4.4
  58. Surveillance
  59. 5.1Division 5.1
  60. 5.2Division 5.2
  61. 5.3Division 5.3
  62. 5.4Division 5.4
  63. Administrative provisions
  64. 6.1Division 6.1
  65. 6.2Division 6.2
  66. 6.3Division 6.3 Repealed
  67. 7Division 7
  68. Annex 3: EC TYPE-EXAMINATION
  69. 1Division 1
  70. 2Division 2
  71. 3Division 3
  72. 4Division 4
  73. 4.1Division 4.1
  74. 4.2Division 4.2
  75. 4.3Division 4.3
  76. 4.4Division 4.4
  77. 5Division 5
  78. 6Division 6
  79. Administrative provisions
  80. 7.1Division 7.1
  81. 7.2Division 7.2
  82. 7.3Division 7.3
  83. 7.4Division 7.4 Repealed
  84. Annex 4: EC VERIFICATION
  85. 1Division 1
  86. 2Division 2
  87. 3Division 3
  88. 4Division 4
  89. 5Division 5
  90. Statistical verification
  91. 6.1Division 6.1
  92. 6.2Division 6.2
  93. 6.3Division 6.3
  94. 6.4Division 6.4
  95. 6.5Division 6.5
  96. 7Division 7
  97. Annex 5: EC DECLARATION OF CONFORMITY TO TYPE
  98. 1Division 1
  99. 2Division 2
  100. Quality system
  101. 3.1Division 3.1
  102. 3.2Division 3.2
  103. 3.3Division 3.3
  104. 3.4Division 3.4
  105. Surveillance
  106. 4.1Division 4.1
  107. 4.2Division 4.2
  108. 4.3Division 4.3
  109. 4.4Division 4.4
  110. 5Division 5
  111. 6Division 6
  112. Annex 6: STATEMENT CONCERNING DEVICES INTENDED FOR SPECIAL PURPOSES
  113. 1Division 1
  114. 2Division 2
  115. 2.1Division 2.1
  116. 2.2Division 2.2
  117. 3Division 3
  118. 3.1Division 3.1
  119. 3.2Division 3.2
  120. 4Division 4
  121. 5Division 5
  122. Annex 7: CLINICAL EVALUATION
  123. General provisions
  124. 1.1Division 1.1
  125. 1.1.1Either a critical evaluation of the relevant scientific literature currently available relating to the safety, performance, design characteristics and intended purpose of the device where:
  126. 1.1.2Division 1.1.2
  127. 1.1.3Division 1.1.3
  128. 1.2Division 1.2
  129. 1.3Division 1.3
  130. 1.4Division 1.4
  131. 1.5Division 1.5
  132. 1.6Division 1.6
  133. Clinical investigation
  134. 2.1Purpose
  135. 2.2Ethical consideration
  136. Methods
  137. 2.3.1Division 2.3.1
  138. 2.3.2Division 2.3.2
  139. 2.3.3Division 2.3.3
  140. 2.3.4Division 2.3.4
  141. 2.3.5Division 2.3.5
  142. 2.3.6Division 2.3.6
  143. 2.3.7Division 2.3.7
  144. Annex 8: MINIMUM CRITERIA TO BE MET WHEN DESIGNATING INSPECTION BODIES TO BE NOTIFIED
  145. 1Division 1
  146. 2Division 2
  147. 3Division 3
  148. 4The staff responsible for control operations must have:
  149. 5Division 5
  150. 6Division 6
  151. 7Division 7
  152. Annex 9CE CONFORMITY MARKING